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Factor IRF-1 Controls Positive and Negative
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The interferon regulatory transcription factor-1 (IRF-1)Australia
is a positive regulatory transcription factor that binds to
a common motif in the promoter region of interferons
(IFNs) and several IFN-inducible genes, including dou-
ble-stranded RNA-dependent protein kinase and H-2KbSummary
(Miyamoto et al., 1988; Harada et al., 1989; Tanaka and
Taniguchi, 1992). It has also been shown that IRF-1Little is known about the molecular mechanisms and
regulates transcription of the peptide transporter TAP1transcriptional regulation that govern T cell selection
(transporter associated with antigen processing-1) andprocesses and the differentiation of CD41 and CD81 T
the proteasome subunit LMP2 (latent infection mem-cells. Mice lacking the interferon regulatory transcrip-
brane protein-2) in thymocytes (White et al., 1996). Micetion factor-1 (IRF-1) have reduced numbers of mature
made deficient in IRF-1 by targetted disruption of theCD81 cells within the thymus and peripheral lymphatic
IRF-1 gene (IRF-12/2) have reduced numbers of matureorgans. Here we show that positive and negative T
CD81CD42 T cells in the thymus but normal numbers
cell selection of two MHC class I±restricted TCRab
of CD41CD82 cells and immature CD41CD81 double-
transgenes, H-Y and P14, are impaired in IRF-12/2 positive thymocytes (Matsuyama et al., 1993; Reis et
mice. The absence of IRF-1 resulted in decreased ex- al., 1994), indicating a lineage-specific alteration in the
pression of LMP2, TAP1, and MHC class I on thymic development of mature TCRab1CD42CD81 T cells.
stromal cells. Despite decreased MHC class I expres- To determine the molecular mechanisms that influ-
sion on IRF-12/2 thymic stromal cells, the defect in ence the development of CD81 thymocytes in IRF-12/2
CD81 T cells development did not reside in the thymic mice, we introduced two MHC class I±restricted TCRab
environment, and IRF-12/2 stromal cells can fully sup- transgenes, H-Y (Teh et al., 1988; von Boehmer, 1990,
port development of CD81 thymocytes in in vivo bone 1993) and P14 (specific for a lymphocyticchoriomeningi-
marrow chimeras and in vitro reaggregation cultures. tis virus (LCMV) glycoprotein peptide [Pircher et al.,
Moreover, IRF-12/2 thymocytes displayed impaired 1989]), into an IRF-12/2 background. We show that posi-
TCR-mediated signal transduction, and the induction tive and negative selection of CD81 T cells are altered
of negative selection in TCR Tg thymocytes from in the absence of IRF-1. IRF-1 expression in thymocytes
IRF-12/2 mice required a 1000-fold increase in select- is induced in a peptide-specific manner, and IRF-1 is
ing peptide. We also provide evidence that IRF-1 is expressed mainly in mature CD41 and CD81 thymo-
mainly expressed in mature, but not immature, thymo- cytes. MHC class I, LMP2, and TAP1 expression in thy-
mic stromal cells and mature thymocytes were impairedcytes and that expression of IRF-1 in immature thymo-
in the absence of IRF-1. Despite decreased MHC classcytes is induced after peptide-specific TCR activation.
I expression, the defect in CD81 T cells developmentThese results indicate that IRF-1 regulates gene ex-
did not reside within thymic epithelial cells, and IRF-12/2pression in developing thymocytes required for line-
stromal cells can fully support development of CD81age commitment and selection of CD81 thymocytes.
thymocytes in in vivo bone marrow chimeras and in vitro
reaggregation cultures. In addition to alterations in MHC
Introduction class I expression, IRF-12/2 thymocytes showed an in-
trinsic signaling defect and were hyporesponsive to a
Physical contacts between T cell receptor (TCR)/CD3 negative-selecting peptide in vitro. These results pro-
vide the first functional evidence that the transcriptioncomplexes and costimulatory molecules on developing
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Figure 1. Thymocyte Development and MHC Class I and II Ex-
pression
(A) Reduced number of CD81 mature thymocytes and CD81 lymph
node T cells in IRF-12/2 mice. IRF-11/2 littermate controls are shown
and relative cell numbers are indicated. Staining procedures are
described in Experimental Procedures. (B) Expression of MHC class
I molecules (H-2Kb) on thymocyte subpopulations and thymic stro-
mal cells in IRF-12/2 and littermate IRF-11/2 mice. Thymocytes were
triple-stained with anti-CD4-PE, anti-CD8-FITC, and anti-H2Kb-bio-
tin. Thymic B cells were visualized with anti-B220-FITC and anti-
H2Kb-biotin. Thymic dendritic cells were stained with the dendritic
cell-specific MAb N418-FITC (anti-CD11c) and anti-H2Kb-biotin.
Similar results were obtained after double-staining with anti-CD11b-
FITC (clone Mac1, reactive with macrophages, dendritic cells, and
granulocytes) and anti-H2Kb-biotin (data not shown). For back-
ground staining, all indicated populations were stained with anti-
H2Kk-biotin (wrong MHC) instead of anti-H2Kb. Background staining
is indicated for CD41CD81 thymocytes as a line histogram. Thymo-
cyte subpopulations, N4181 dendritic cells, and B2201 cells were
electronically gated for H2Kb expression on a FACSscan. Mean H2Kb
expression levels are indicated. One result representative of four
independent experiments is shown.
(C) Expression of MHC class I (H-2Kb) and MHC class II (I-Ab) mole-
cules on thymic epithelial cells isolated from IRF-12/2 and littermate
IRF-11/2 mice. Purified thymic epithelial cells (Lahoud et al., 1993)
were double-stained using CD45-FITC (all epithelial cells are
CD452), and anti-H2Kb-biotin (filled histograms), anti-H2Kk-biotin
(controls, line histograms), and anti-IA-PE. Control line histograms
represent unstained epithelial cells. Thymic epithelial cells were de-
fined as CD452, FSChi, SSChi cells and electronically gated for H2Kb,
H2Kk, or I-Ab expression. It should be noted that thymic epithelial
cells accounted for 30%±40% of cells after purification. Mean ex-
pression levels are indicated. One result representative of three
independent experiments is shown.
factor IRF-1 regulates gene expression in stromal cells I (H-2Kb), TAP1, and LMP2 promoters (Tanaka and Tani-
guchi, 1992; White et al., 1996), we analyzed MHC classand, more importantly, in developing thymocytes re-
quired for lineage commitment and selection of CD81 I expression on thymocyte subpopulations and thymic
stromal cells of IRF-12/2 mice. As shown in Figures 1Bthymocytes.
and 1C, the expression of surface MHC class I (H-2Kb)
molecules in IRF-12/2 mice was down-regulated (asResults
compared to IRF-11/2 mice) on thymic stromal cells and
mature CD41 and CD81, but not immature CD41CD81IRF-1 Controls MHC Class I Expression
IRF-12/2 mice have a defect in the development of CD81 thymocytes. By contrast, MHC class II expression (I-Ab)
on thymic epithelial cells was comparable between IRF-T cells that results in a greatly reduced numberof periph-
eral CD81 lymphocytes (Figure 1A and Matsuyama et 11/2 and IRF-12/2 mice (Figure 1C). In addition, expres-
sion of LMP2, TAP1, and the MHC class I heavy chainal., 1993). CD81 cells are selected on MHC class I mole-
cules, and perturbations in the levels of MHC class I (H-2Kb) mRNAs was decreased in the absence of a func-
tional IRF-1 gene (Figure 2). These data indicate thatexpression have been shown to alter the selection of
CD81 thymocytes (Berg et al., 1990; Sha et al., 1990; IRF-1 is a general transcriptional activator of molecules
involved in MHC class I expression.Ohashi et al., 1993). Since IRF-1 binds to the MHC class
IRF-1 Controls CD81 T Cell Selection
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P14 TCR isspecific for an epitope of the LCMV glycopro-
tein in the context of H-2Db (Pircher et al., 1989). In
H-2b/b mice, thymocytes expressing the P14 TCR were
positively selected to the CD81 single-positive lineage
(Figure 5A). Skewing to mature CD81 thymocytes was
impaired in positive-selecting H-2b/b IRF-12/2 mice, and
maturation of P14 Tg thymocytes was partially blocked
at the CD41CD81 double-positive stage of differentia-
tion (Figure 5A).However, CD81CD4lo cellsstill displayed
up-regulated expression of the P14 Tg TCRVa2 chain
(Figure 5A) and the maturation markers CD5 and CD69
(data not shown). The number of peripheral TCR Tg
CD81 T cells was significantly reduced in P14 IRF-12/2
mice (Figure 5B). These data show that positive selec-
tion of H-Y and P14 TCR Tg thymocytes is severely
impaired in the absence of the transcription factor IRF-1.
Impaired Negative Selection in H-Y Tg Mice
Negative selection in male H-Y Tg mice results in the
depletion of CD41CD81 thymocytes (Figure 6A) and aFigure 2. Expression of LMP2, TAP1, and MHC Class I Heavy Chain
(H-2Kb) mRNA in Thymocytes of IRF-12/2 and Littermate IRF-11/2 skewing of CD4/CD8 ratios (z1:5) in peripheral lym-
Mice phatic organs (Figure 6B). CD8lo lymph node T cells
Total thymocyte populations were isolated and hybridized to probe represent cells that have escaped negative selection by
sequences specific for LMP2, TAP1 and H-2Kb (top). b-actin is down-regulation of the CD8 coreceptor (BluÈ thmann et
shown as a control (bottom). Relative expression levels were normal-
al., 1988; Kisielow et al., 1988). By contrast, male H-Y Tgized to b-actin mRNA expression and determined by phosphor-
IRF-12/2 mice contained a large number of CD41CD81Imaging. Levels of mRNA expression in IRF-11/2 mice were taken
thymocytes (Figure 6A), and the ratio of CD4:CD8 cellsas 100%.
(z2:1) was significantly altered in mesenteric lymph
nodes (Figure 6B). The majorityof thymocytes and CD81Impaired Positive Selection in TCR
peripheral T cells in male IRF-12/2 and IRF-11/2 miceTransgenic IRF-12/2 Mice
coexpressed the Tg TCR (T3.701) (Figure 6).To analyze the molecular mechanisms responsible for
the developmental block of CD81 thymocytes in IRF-
12/2 mice, we crossed two mouse lines carrying MHC IRF-1 Regulates Peptide-Specific Deletion
of P14 Tg Thymocytesclass Ibrestricted transgenic (Tg) TCRs into an IRF-12/2
background (Matsuyama et al., 1993), the H-Y transgene To elucidate the requirement for IRF-1 in negative selec-
tion, a peptide-specific in vitro negative selection sys-(Teh et al., 1988) and the P14 transgene (Pircher et al.,
1989). The H-Y TCR recognizes a male specific peptide tem was employed. In this system, MC57/L fibroblasts
(H-2b/b) are loaded with different concentrations of ain the context of self-MHC class I (H-2Db) molecules.
Thymocytes expressing the H-Y TCR are positively se- negative-selecting LCMV glycoprotein peptide and in-
cubated with purified P14 thymocytes. P14 thymocyteslected in female H-2b mice, negatively selected in male
H-2b mice, and blocked at a CD41CD81 immature stage in which the negative selection apparatus is intact are
deleted in response to the presence of the LCMV peptidein H-2d/d mice (nonselection) (von Boehmer, 1990). In
positive-selecting female H-Y mice, Tg T cells were (Pircher et al., 1993). Down-regulation of CD4 and CD8
molecules (Figure 7) and cell death of CD41CD81 thymo-skewed toward the CD8 lineage and coexpressed the
Tg TCR detected by the monoclonal antibody (MAb) cytes (Figure 8) occurred in a dosage-dependent fashion
in IRF-11/2 mice, consistent with previous studiesT3.70 (Figure 3A). In contrast, skewing of mature CD81
thymocytes did not occur in nonselecting H2d/d mice, (Pircher et al., 1993). Deletion of IRF-11/2 P14 thymo-
cytes already occurred at a dose of 1029 mol/ml. Induc-and mature CD81 thymocytes down-regulated the ex-
pression of the Tg TCR. Thymocytes from positive- tion of negative selection of IRF-12/2 P14 thymocytes
required an approximately 1000-fold higher concentra-selecting H-Y IRF-12/2 mice displayed only a minimal
skewing toward mature CD81 T cells (Figure 3A). How- tion of the deleting LCMV glycoprotein peptide than that
required in IRF-11/2 mice (Figures 7 and 8). Cell deathever, CD81 thymocytes from H-Y IRF-12/2 mice still
coexpressed and up-regulated expression of the Tg of P14 Tg thymocytes cocultured with MC57/L fibro-
blasts in the absence of peptide was comparable be-T3.70 TCR (Figure 3A). Moreover, T3.70hi cells up-regu-
lated the maturation markers CD5 (data not shown) and tween IRF-11/2 and IRF-12/2 mice (,10%). In addition,
IRF-12/2 thymocytes were more resistant to the induc-CD69 (Figure 3B). In addition, Tg expression of the H-Y
TCR did not restore to normal the numbers of CD81 T tion of apoptosis in response to anti-CD3e crosslinking
(data not shown). Similar results were obtained usingcells in lymph nodes (Figure 4) or in spleens (data not
shown) of IRF-12/2 mice. thymocytes from LCMV Tg allogeneic nonselecting
(H-2d/d) IRF-12/2 and IRF-11/2 and LCMV Tg b2m2/2 miceTo examine further the role of IRF-1 in positive selec-
tion, the development of thymocytes expressing the P14 (Sebzda et al., 1994), in which the Tg TCR has never
been engaged by the selecting peptide/MHC class ITg TCR (Va2/Vb8) was evaluated in IRF-12/2 mice. The
Immunity
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Figure 3. IRF-1 Is Required for Positive Selection of H-Y TCR Tg Thymocytes
(A) Impaired positive T cell selection of H-Y TCR Tg thymocytes in IRF-12/2 mice. Genotypes of 8 week old mice are indicated. Thymocytes
(1 3 106) were triple-stained with anti-CD4-PE, CD8-FITC, and the H-Y TCR specific MAb T3.70-biotin followed by streptavidin-RED670.
Numbers in dot blots indicate percentages of CD41 and CD81 thymocyte subpopulations in each quadrant. Filled histograms show T3.70
expression on gated immature CD41CD81 and CD81 single-positive thymocytes. Line histograms show background staining. Total thymocyte
numbers were: IRF-11/2H2d/d nonselecting female, 2.9 3 107; IRF-11/2H2b/b positive-selecting female, 1.8 3 107; and IRF-12/2 H2b/b positive-
selecting female, 2.6 3 107. Staining protocols and analysis are described in Experimental Procedures. One result representative of four
independent experiments is shown.
(B) CD69 expression on gated immature CD41CD81 and CD81 single-positive thymocyte populations. Thymocytes from positive-selecting
female H-Y IRF-12/2 and H-Y IRF-11/2 Tg mice were triple stained with anti-CD4-PE, anti-CD8-biotin, and anti-CD69-FITC, and populations
were electronically gated. Data are from the same mice as in Figure 3A. One result representative of three experiments is shown.
complex. Thus, IRF-12/2 thymocytes require a 1000-fold thymic epithelial cells or bone marrow±derived cells
were responsible for the reduced number of matureincrease in the peptide dose presented by wild-type
fibroblasts for the induction of apoptosis, as compared CD81 cells within the thymus and peripheral lymphatic
to IRF-11/2 or b2m2/2 thymocytes (data not shown). organs of IRF-12/2 mice, rescue by the generation of
However, no significant differences were observed be- bone marrow chimeras was undertaken.
tween IRF-12/2 and IRF-11/2 thymocytes in either the Transplantation of Thy1.11IRF-11/1 bone marrow cells
extent or kinetics of cell death in response to dexameth- into irradiated congenic Thy1.21IRF-12/2 recipients was
asone (data not shown). These data show that IRF-1 found to rescue the development of CD81CD42 T cells
regulates TCR-mediated cell death of developing thy- within the thymus and peripheral lymphatic organs (Fig-
mocytes. ure 9A). In the reciprocal experiment, CD81 T cell devel-
opment was not restored in chimeras generated from
Thy1.21IRF-12/2 bone marrow cells transferred into irra-The Developmental Defect of CD8 Lineage
diated Thy1.11IRF-11/1 mice (Figure 9A). Moreover, inSelection Is Intrinsic to IRF-12/2 Thymocytes
a peptide-specific in vitro reaggregation culture for posi-The results described above showed that IRF-1 regu-
tive selection (Chidgey et al., 1997), purified thymic stro-lates the expression of MHC class I molecules in mature
mal cells from IRF-12/2 mice could fully support thethymocytes and thymic stromal cells (Figures 1 and 2).
differentiation of LCMV TCR Tg immature CD41CD81However, the in vitro negative selection of P14 Tg thymo-
thymocytes from b2m2/2 mice (which were used to avoidcytes induced by fibroblasts expressing a defined level
the possibility that these cells have previously signaled)of surface MHC class I was impaired. This finding sug-
to CD81 T cells (Figure 9B and Table 1). These resultsgested that IRF-12/2 T cells might also have an intrinsic
indicate that IRF-12/2 mice exhibit a defect in CD81defect in lineage specific selection that was indepen-
dent of MHC class I expression. To investigate whether thymocyte maturation that is intrinsic to thymocytes and
IRF-1 Controls CD81 T Cell Selection
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Developmental Control of IRF-1 Expression
The results of the selection experiments described
above indicated that IRF-1 controls positive and nega-
tive selection of CD81 thymocytes. To determine IRF-1
expression at the genetic level during T cell selection,
we analyzed IRF-1 mRNA expression in mouse strains
that harbor defined genetic mutations in various stages
of T cell selection and lineage commitment. CD452/2
mice (Kishihara et al., 1993) have a developmental
block at the first step of positive selection (CD41CD81
CD5loCD692) (Kozieradzki et al., 1997). CD42/2 mice (Ra-
hemtulla et al., 1991) lack CD41 T cells but have normal
development of CD81 thymocytes. CD82/2 mice (Fung-
Leung et al., 1991) have a block in the selection of CD81
T cells but show normal CD41 T cell development. Al-
though only the development of CD81 cells was blocked
in IRF-12/2 mice, IRF-1 mRNA was detected at normal
levels in both CD42/2 and CD82/2 mice (Figure 11A).
However, IRF-1 mRNA expression was virtually absent
in thymocytes from CD452/2 mice (Figure 11A), implying
that IRF-1 is not expressed in immature thymocytes that
cannot undergo positive selection.
To investigate IRF-1 expression in wild-type thymo-
cytes, we analyzed IRF-1 protein expression in cell-
sorted immature CD41CD81TCRlo and mature CD41
TCRhi and CD81TCRhi subpopulations. Whereas IRF-2
and Cbl-2 expression levels were comparable among
all populations, IRF-1 protein was nearly absent in
CD41CD81 thymocytes (Figure 11B). Similar results,
Figure 4. H-Y Tg T Cells in Mesenteric Lymph Nodes of Positive- namely absence of IRF-1 in CD41CD81 thymocytes,
Selecting IRF-12/2 and IRF-11/2 H-2b/b Female Mice and Nonselect- were obtained by reverse transcription polymerase
ing H-2d/d Female IRF-11/2 Control Mice chain reacton using primers specific for IRF-1, IRF-2,
Immunofluorescence staining was as in Figure 3A. Numbers in dot and G3PDH (data not shown). Moreover, peptide-spe-
blots indicate percentages of CD41 and CD81 T cells. Histograms
cific activation of b2m2/2 LCMV (P14) Tg and CD452/2show T3.70 expression on gated CD41 and CD81 T cells. Total cell
P14 Tg thymocytes triggered IRF-1, but not IRF-2 ornumbers were: IRF-11/2H2d/d, 1.4 3 107; IRF-11/2H2b/b female, 6.1 3
Cbl-2, up-regulation in thymocytes (Figure 11C).106; and IRF-12/2 H2b/b female, 9 3 106. Data are from the same
mice as in Figure 3.
Discussion
bone marrow-derived cells. This defect is independent
The results of this study show that IRF-1 and the IFN-of host thymic epithelium.
regulated transcriptional machinery have a pivotal role
in the selection of immature CD41CD81 thymocytes to
mature TCRab1CD81 single positive T cells. PositiveImpaired Phosphotyrosine Signaling
in IRF-12/2 Thymocytes and negative T cell selection were impaired in H-Y and
P14 TCR Tg IRF-12/2 mice. Peptide-specific negativeTo test whether the defect in positive and negative CD8
lineage selection in IRF-12/2 mice was associated with selection of P14 TCR Tg thymocytes correlated with the
concentration of the deleting-peptide. The impairmenta defect in signal transduction, we investigated phos-
photyrosine signal transduction in IRF-11/2 and IRF-12/2 in the selection of MHC class I restricted CD81 thymo-
cytes in IRF-12/2 mice could be explained by a defectthymocytes in response to anti-CD3e crosslinking. Fig-
ure 10A shows that at all time points examined, levels in MHC class I expression on thymic stromal cells and
by an intrinsic defect in T cells that prevents them fromof phosphotyrosine signal transduction were markedly
reduced in IRF-12/2 thymocytes compared to IRF-11/2 responding to the TCR-mediated signals involved in
positive and negative selection. Although previous (Ta-thymocytes. A similar reduction in TCR/CD3-mediated
signal transduction in IRF-12/2 thymocytes was ob- naka and Taniguchi, 1992; White et al., 1996) and our
own results show that IRF-1 controls transcriptional in-served after anti-CD3e/anti-CD4 or anti-CD3e/anti-CD8
crosslinking (data not shown). However, the levels of duction of molecules involved inMHC class Iexpression,
our data provide clear evidence that the defect in IRF-p56lck, ZAP-70, and Cbl-2 protein expression were com-
parable between total IRF-11/2 and IRF-12/2 thymocyte 1-deficient mice is in the thymocyte population, but not
in the selecting environment.lysates (Figure 10B). Expression levels of p56lck, ZAP-
70, and Cbl-2 were also comparable among CD41CD81, It has been previously proposed that positive selec-
tion of CD81 thymocytes occurs in two steps (Chan etCD41CD82, and CD42CD81 thymic subpopulations iso-
lated from IRF-12/2 and IRF-11/2 mice (data not shown). al., 1993, Davis et al., 1993; van Meerwijk and Germain,
Immunity
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Figure 5. Impaired Positive Selection of P14 TCR Tg T Cells
(A) Positive T cell selection of LCMV glycoprotein specific P14 (TCRVa2/Vb8) Tg thymocytes in H-2b/b IRF-11/2 and IRF-12/2 mice. Genotypes
of mice are indicated. Thymocytes were triple-stained with anti-CD4-PE, anti-CD8-FITC, and anti-TCRVa2 (specific for the P14 Tg TCRa
chain). Numbers in dot blots indicate percentages of CD41 and CD81 thymocyte subpopulations in each quadrant. Histograms show TCRVa2
expression on gated immature CD41CD81 and CD81 single-positive thymocytes. Total thymocyte numbers were: IRF-11/2H2b/b positive-
selecting, 1.6 3 107; IRF-12/2 H2b/b positive-selecting, 1.4 3 107. Data are representative of three independent experiments.
(B) P14 Tg T cells in mesenteric lymph nodes of positive-selecting IRF-12/2 and IRF-11/2 mice. Immunofluorescence staining was as in Figure
5A. Numbers in dot blots indicate percentages of CD41 and CD81 populations. Histograms show TCRVa2 expression on gated CD41 and
CD81 T cells. Total cell numbers were: IRF-11/2, 5.7 3 106; IRF-12/2, 4.4 3 106. Data are from the same mice as shown in Figure 5A.
1993; Pircher et al., 1994; von Boehmer, 1996). The first levels in CD42/2 and CD82/2 (Lyt22/2) thymocytes. We
propose that a TCR-mediated CD45-dependent signalselection step results in the appearance of CD41CD8int
and CD4intCD81 thymocytes; the second selection step at the first step of positive T cell selection induces IRF-1
expression. IRF-1 may then regulate molecular eventsrequires the interaction of CD8 or CD4 coreceptors with
MHC class I or class II molecules. The first step is also that control T cell survival during the second step of
positive selection and transactivate genes involved inassociated with changes in surface markers in response
to TCR-mediated activation (Chan et al., 1993, Davis et lineage commitment and selection of CD81 thymocytes
(Figure 12). However, it should be noted that other mod-al., 1993; van Meerwijk and Germain, 1993; Pircher et
al., 1994), including the up-regulation of TCR, CD5, and els for lineage commitment exist (von Boehmer, 1996).
Since developing thymocytes normally up-regulateCD69 expression (Crispe and Bevan, 1987; BraÈ ndle et
al., 1994). An intermediate CD4loCD81 thymocyte popu- MHC class I expression and since CD81CD4lo cells must
recognize MHC class I for final maturation, it may belation was observed in IRF-12/2 mice in which P14 Tg
and H-YTg thymocytes displayed normally up-regulated thought that MHC class I molecules on developing thy-
mocytes are involved in positive selection of CD81 Texpression of the Tg TCR, CD5, and CD69. The expres-
sion patterns of these maturation markers and the pres- cellsÐin other words, that developing thymocytes can
select each other. However, there is no evidence in anyence of a CD4loCD81 thymocyte population in IRF-12/2
TCR Tg mice implies that theCD81 developmental arrest in vivo or in vitro experimental system to support this
notion. Signals by thymic stromal cells (including epithe-occurs at the second step of positive T cell selection
(Figure 12). lial cells, macrophages, and dendritic cells) have been
shown to be crucial for mediating the positive and nega-The first stage of positive selection also leads to the
up-regulation of MHC class I molecules on developing tive selection of thymocytes (Boyd et al., 1993). Thymic
epithelial cells within the cortex are the primary stromalthymocytes (van Meerwijk and Germain, 1993). Whereas
mature CD41 and CD81 thymocytes from IRF-11/2 mice cell subset that mediates positive T cellselection and the
differentiation of both CD41 and CD81 T cell lineages,up-regulated H-2Kb expression, a similar effect was not
observed in IRF-12/2 mice (Figure 1B), implying that whereas bone marrow±derived macrophages and den-
dritic cells located in the thymic medulla and corti-IRF-1 transcriptional activity is required for the increase
from baseline of MHC class I expression during selec- comedullary junction appear to mediate negative selec-
tion (Benoist and Mathis, 1989; Schwartz, 1989; Hugotion. IRF-1 was virtually absent in immature CD41CD81
thymocytes and in CD452/2 mice, which exhibit a block et al., 1992; Vukmanovic et al., 1992; Boyd et al., 1993;
von Boehmer, 1993; Anderson et al., 1994; Laufer et al.,at the first step of positive selection of H-Y and P14
Tg thymocytes (Kozieradzki et al., 1997; Wallace et al., 1996). While it has been reported in some experimental
systems that bone marrow cells and mesenchymal fibro-1997). Moreover, peptide-specific-TCR activation is a
strong inducer of IRF-1 expression in thymocytes (Fig- blasts are capable of inducing positive T cell selection
(Bix and Raulet, 1992; Hugo et al., 1993; Pawlowski eture 11). However, IRF-1 mRNA was present at normal
IRF-1 Controls CD81 T Cell Selection
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Figure 7. Impaired In Vitro Negative Selection of P14 Thymocytes
in Response to Different Concentrations of Deleting LCMV Glyco-
protein Peptide
Thymocytes were purified from IRF-11/2 and IRF-12/2 P14 (LCMV)
Tg H-2b/b mice and cultured on a monolayer of adherent MC57/L
fibroblasts (H-2b/b) pulsed with different concentrations (moles per
milliliter) of the deleting LCMV peptide. Induction of clonal deletion
leads to down-regulation of CD4 and CD8 expression on CD41CD81
thymocytes (Pircher et al., 1993). The percentages of CD41CD81
Figure 6. IRF-1 Regulates Negative Selection of H-Y TCR Tg Thy- and CD4loCD8lo populations are indicated. One result representative
mocytes of six independent experiments is shown.
(A) Impaired negative selection of H-Y Tg1 thymocytes in male IRF-
11/2 and IRF-12/2 mice. Genotypes and staining procedures were
as described in Figure 3. Numbers indicatepercentages of CD41 and
expression on thymic stromal cells, our data provideCD81 cells. Histograms show T3.70 expression in total thymocytes.
clear evidence that the defect in IRF-1-deficient miceThymocyte numbers were: IRF-11/2H2b/b male, 3.8 3 106; IRF-
resides within the thymocyte population but not in the12/2H2b/b male, 9 3 106. Negative-selecting IRF-12/2 and IRF-11/2
male mice were 4 weeks of age. Similar results were obtained in selecting environment. It should be noted that ourexper-
two additional independent experiments. iments provide the first solid evidence that IRF-1 does
(B) Reduced number of CD81 lymph node T cells in negative-select- control MHC-I expression on thymic stromal cells.
ing male IRF-12/2 mice. Immunofluorescence staining was as in Mice lacking either TAP1 (Van Kaer et al., 1992), LMP2
Figure 4. Numbers in dot blots indicate percentages of CD41 and
(van Kaer et al., 1994) or IRF-1 (Matsuyama et al., 1993;CD81 T cells among total mesenteric lymph node cells. Histograms
Reis et al., 1994) all have a similar phenotype, definedshow T3.70 expression among gated CD41 and CD81 T cells. Total
cell numbers were: IRF-11/2H2b/b male, 2 3 107; IRF-12/2H2b/b male, by a developmental block of MHC class I±restricted
1.1 3 107. Data are from the same mice as shown in Figure 6A. thymocytes. Whereas genetic deletion of the peptide
transporter TAP1 or the proteasome subunit LMP2 leads
to impaired peptide loading of MHC class I molecules
and subsequent impaired maturation of MHC classal., 1993), the induction of positive selection by bone
marrow±derived stromal cells was limited and weaker I±restricted CD81 T cells, ineffective positive and nega-
tive selection in IRF-12/2 mice cannot be attributedthan positive selection mediated by thymic epithelial
cells. The finding that IRF-1 is a principal transcriptional solely to alterations in MHC class I expression, for the
following reasons. First, CD81 T cell maturation was stillinducer of LMP2, TAP1 (White et al., 1996), and MHC
class I heavy chain genes in various cell types including defective in bone marrow chimeras in which IRF-12/2
bone marrow cells were used to seed the IRF-11/1 epi-thymic dendritic cells (Figures 1 and 2) supports the
contention that deregulated MHC class I expression on thelial thymic microenvironment (IRF-12/2→IRF-11/1
chimeras); however, CD81 T cells in IRF-11/1→IRF-12/2thymic stromal cells leads to impaired positive and neg-
ative selection of TCR Tgthymocytes. Although previous chimeras developed normally. Second, in a peptide-
specific in vitro model of positive selection, purified thy-(Tanaka and Taniguchi, 1992; White et al., 1996) and
our own results show that IRF-1 regulates MHC class I mic stromal cells from IRF-12/2 mice fully supported
Immunity
250
Table 1. Selection of P14 TCR Tg b2m2/2 thymocytes in in vitro
Reaggregation Cultures
IRF11/2 Stroma IRF12/2 Stroma
Experiment 1
CD41CD81 50% 45%
CD42CD81 37% 40%
CD41CD82 6.7% 8.3%
Experiment 2
CD41CD81 44% 54%
CD42CD81 34% 29%
CD41CD82 3.4% 7%
Experiment 3
CD41CD81 42% 41%
CD42CD81 30% 27%
CD41CD82 9% 13%
Thymocytes were isolated from P14 Tg b2m2/2 mice (embryonic day
17) and activated with 1029 mol/ml LCMV peptide in the presence
of IRF11/2 (H-2b/b) or IRF12/2 (H-2b/b) stromal cells. Thymocyte sub-Figure 8. Impaired Induction of Cell Death of P14 Tg Thymocytes
populations were analyzed as described in Figure 9B and Experi-in Response to Different Concentrations of Deleting LCMV Glyco-
mental Procedures. Relative percentages of different subpopula-protein Peptide
tions after 4 days of culture are indicated. CD81CD42 cellsP14 Tg thymocytes were purified from IRF-11/2 and littermate
expressed both transgenic TCRab chains at high levels and wereIRF-12/2 mice and cultured on LCMV glycoprotein peptide-pulsed
functional in in vitro proliferation assays (data not shown).MC57/L fibroblasts. Cells were harvested after 22 hr of culture and
cell death was determined by FACS staining using anti-CD4-PE,
anti-CD8-FITC, and the vital dye 7AAD. Dose response curves are
shown for three individual IRF-11/2 and three IRF-12/2 P14 Tg mice. Conclusion
Percentages of survival are the percentages of viable CD41CD81
Little is known about the molecular mechanisms andthymocytes cultured at different LCMV peptide concentrationscom-
transcriptional regulation that govern T cell selectionpared to control thymocytes cultured in the absence of LCMV pep-
processes and the differentiation of CD41 and CD81 Ttide. Similar results were obtained in six independent experiments.
cells. We show in two different CD81 TCRab Tg mouse
models that IRF-1 regulates positive and negative selec-
tion of MHC class I±restricted thymocytes. IRF-1 is adevelopment of wild-type thymocytes. Third, peptide-
principle transcriptional inducer of genes involved in thespecific clonal deletion of P14 IRF-12/2 thymocytes was
processing and presentation of peptides in associationimpaired although the peptides were presented by fibro-
with MHC class I. Despite decreased MHC class I ex-blasts at the same concentration and these fibroblasts
pression on thymic stromal cells, the defect in CD81 Texpress MHC class I at the same levels on the cell
cells development did not reside in the thymic microen-surface. These results indicate that IRF-1 regulates a
vironment, and IRF-12/2 stromal cells can fully supportgene in developing thymocytes, the product of which is
development of CD81 thymocytes in in vivo bone mar-crucially involved in signal transduction in thymocytes
row chimeras and in vitro reaggregation cultures. More-and lineage specific differentiation of CD81 cells.
over, IRF-12/2 thymocytes displayed impaired TCR-Several signal transduction molecules are involved in
mediated signal transduction, and the inductionof nega-T cell selection. Mice lacking the CD45 protein tyrosine
tive selection in TCR Tg thymocytes from IRF-12/2 micephosphatase (Kishihara et al., 1993), the guanine-nucle-
required a 1000-fold increase in selecting peptide. IRF-1otide exchange factor p95vav (Tarakhovsky et al., 1995;
protein is virtually absent in immature CD41CD81 thy-Zhang et al., 1995), or the ZAP-70 kinase (Negishi et al.,
mocytes and in CD452/2 mice that exhibit a block at the1995) exhibit a block in the maturation of both CD41
first step of positive selection. A peptide-specific signaland CD81 lineages (Kishihara et al., 1993). In human
induces IRF-1 expression in immature TCR Tg thymo-selective T cell deficiency, mutation of the ZAP-70 tyro-
cytes. These results indicate that IRF-1 regulates genesine kinase abrogates the development of only CD81
expression in developing thymocytes required for line-thymocytes (Arpaia et al., 1994; Elder et al., 1994). It has
age commitment and selection of CD81 thymocytes. Aalso been shown that CD4loCD81 transitional thymo-
model of transcriptional regulation of CD81 thymocytecytes contain high levels of a 70 kDa phosphorylated
selection by IRF-1 is proposed (Figure 12).protein (presumably ZAP-70), leading the authors topro-
pose a role for ZAP-70 in the signal transduction during
Experimental Procedures
the positive selection of CD8 cells (Benveniste et al.,
1996). Although the levels of ZAP-70, p56lck, and Cbl-2 Mice
were unaltered in IRF-12/2 thymocytes, our experiments Mice made deficient in IRF-1, CD45, CD4, or CD8 expression by
homologous recombination, and H-Y and P14 TCR Tg, P14 Tgpreclude neither a discriminatory role for signaling pro-
b2m2/2, and P14 Tg CD452/2 mice have been described previouslyteins such as ZAP-70 in lineage commitment nor their
(Teh et al., 1988; Pircher et al., 1989; Fung-Leung etal., 1991; Rahem-differential regulation in this process. Moreover, differ-
tulla et al., 1991; Kishihara et al., 1993; Matsuyama et al., 1993;
ent thymocyte lineages may have different requirements Sebzda et al., 1994; Kozieradzki et al., 1997). Mice were screened
for transcriptional control, signal transduction, or sur- for the TCR Tg using MAbs against the Tg TCRVb8 chain. The IRF-1
mutation was identified using genomic Southern blotting of tail DNAvival factors during maturation (von Boehmer, 1996).
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Figure 9. IRF-1 Stromal Cells Support Differentiation of P14 TCR Tg CD41CD81 Thymocytes into CD81 T Cells
(A) Bone marrow reconstitution of Thy1 congenic IRF-12/2 and IRF-11/1 mice. CD4-PE and CD8-FITC staining of thymic and mesenteric lymph
node cells are shown. Nontransplanted and age-matched IRF-12/2 and IRF-11/1 mice are shown as controls. Numbers indicate percentages
of CD41 or CD81 T cells among total LN cells. Total mesenteric LN cell numbers were: 1.9 3 107 for IRF-12/2 control mice; 1.55 3 107 for
IRF-11/1 control mice; 6 3 106 for IRF-11/1→IRF-12/2 chimeras; and 1.5 3 107 for IRF-12/2→IRF-11/1 chimeras. Percentages of chimerism
were determined by staining for Thy1.1-FITC and CD3-PE or Thy1.2-FITC and CD3-PE: IRF-12/2→IRF-11/1 chimeras: 2.7% Thy1.11 host and
97.3% Thy1.21 donor LN T cells; IRF-11/1→IRF-12/2 chimeras: 22.1% Thy1.21 host and 77.9% Thy1.11 LN donor T cells.
(B) IRF-1 stromal cells support differentiation of P14 TCR Tg CD41CD81 thymocytes into CD81 T cells in an in vitro reaggregation culture.
Thymocytes were isolated from Ly5.21 congeneic P14 b2m2/2 mice (embryonic day 17) and cultured for 4 days with thymic stromal cells
isolated from Ly5.1 congeneic IRF-11/2 or IRF-12/2 (H-2b/b) mice or nonselecting stromal cells isolated from CBA (H-2k/k) mice (bottom). Thymic
stromal cells were pulsed with 1029 mol/ml LCMV peptide as described in Experimental Procedures. After 4 days of cultures cells were
harvested, stained with anti-CD4 (PE), anti-CD8 (biotin), anti-CD3 (APC), and anti-Ly5.1 (FITC) and analyzed using a FACScan. Electronically
gated Ly5.21 cells are shown in contour graphs. Numbers in quadrants indicate relative numbers of thymocyte subpopulations. One experiment
representative for three independent experiments is shown.
as described (Matsuyama et al., 1993). Thy1.11B6PL-Thy.1Acy mice (PE-labeled, PharMingen). All staining combinations were as indi-
cated in the figure legends. Biotinylated MAbs were visualized withwere purchasedform the Jackson Laboratories. Care of animals was
in accordance with guidelines of the Canadian Research Council. streptavidin-RED670 (Gibco Laboratories), and samples were ana-
lyzed using a FACScan and the Lysis II program (Becton Dickinson).
Immunocytometry
Blood samples (20 ml) were collected in heparinized capillary tubes Northern Blotting
RNA was isolated from total thymocytes using guanidine isothiocya-and washed once in immunofluorescence staining buffer (phos-
phate-buffered saline [PBS], 1% fetal calf serum [FCS], and 0.01% nate extraction. Five micrograms of total RNA were electrophoresed
on 5.5% formaldehyde/1% agarose gels, transferred to nitrocellu-NaN3). Single-cell suspensions from thymocytes, spleen cells, and
mesenteric lymph node cells were prepared as described (Kishihara lose membranes, and hybridized with probes to LMP2, TAP1, MHC
class I heavy chain (H-2Kb), IRF-1, orb-actin. Hybridizedmembraneset al., 1993), resuspended in PBS and incubated with appropriate
MAbs (30 min at 48C). Thymic stromal cell populations were isolated were exposed and imaged, and LMP2, TAP1, and H-2Kb mRNA
levels were compared to b-actin mRNA. The relative levels of mRNAsas described by Lahoud et al. (1993). The following MAbs were
used: anti-CD4 (fluorescein isothiocyanate [FITC]± or phycoerythrin were quantified using a PhosphorImager (ImageQuant software,
Molecular Dynamics).[PE]±labeled, PharMingen); anti-CD8 (FITC- or PE-labeled or biotin-
ylated, Serotec); anti-pan TCRVb (FITC- or PE-labeled,PharMingen);
anti-TCRVb8.118.2 (clone KJ16, PE-labeled or biotinylated, Phar- In Vitro Negative Selection
Thymocytes were purified from IRF-11/2 and IRF-12/2 P14 (LCMV)Mingen); anti-H-2Kb (FITC- or biotin-labeled, PharMingen); anti-H-
2Kd (FITC-labeled, PharMingen); anti-H-2Kk (FITC- or biotin-labeled, Tg H-2b/b mice, and1 3 106 thymocytes were cultured on a monolayer
of adherent MC57/L fibroblasts (H-2b/b) in RPMI medium (5% FCS,PharMingen); anti-I-Ab (PE-labeled, PharMingen); anti-pan CD45
(FITC-labeled, PharMingen); anti-CD11b (clone Mac1, FITC-labeled, 1025 M b-mercaptoethanol) (2 ml final volume, 24-well Costar flat-
bottom plates). MC57/L fibroblasts (H-2b/b) were pulsed with differentPharMingen); anti-CD11c (clone N418, specific for murine dendritic
cells, FITC-labeled, a kind gift from N. Romani, Innsbruck, Austria); concentrations (moles per milliliter) of the deleting LCMV peptide for
2 hr before coculture with thymocytes (Pircher et al., 1993; Sebzda etanti-B220 (FITC-labeled, PharMingen); anti-CD5 (FITC-labeled,
PharMingen); anti-CD69 (FITC-labeled, PharMingen); anti-CD3e al., 1994). Thymocytes were harvested after 22 hr of incubation and
stained with anti-CD4-PE, anti-CD8-FITC, and the chromogenic dye(FITC- or PE-labeled, PharMingen); anti-Thy1.2 (FITC- orPE-labeled,
PharMingen); anti-Thy.1.1 (FITC-labeled, Serotec); anti-HY TCR clo- 7-amino-actinomycin-D (7-AAD) (Calbiochem, San Diego, CA).
7-AAD is a vital dye that enters dead cells after loss of membranenotype (T3.70, FITC-labeled or biotinylated); and anti-P14 TCRVa2
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Figure 10. Impaired Phosphotyrosine Signaling in IRF-12/2 Thymo-
cytes
(A) Phosphotyrosine signaling in IRF-12/2 and IRF-11/2 thymocytes.
Total thymocytes (1 3 106 per sample) were activated for 0, 2, 5,
and 20 min with anti-CD3e as indicated and phosphoproteins visual- Figure 11. Regulation of IRF-1 Expression in Thymocytes
ized as described in Experimental Procedures. Similar results were
(A) Expression of IRF-1 mRNA in thymocytes of mice deficient in theobtained in three independent experiments.
CD45, CD4 or CD8 genes. Thymocytes were isolated from CD451/2,(B) Protein expression levels of p56lck, ZAP-70, and Cbl-2 in total
CD452/2; CD41/2, CD42/2; CD81/2 and CD82/2 littermate mice. Thethymocytes (1 3 106) of IRF-11/2 and IRF-12/2 mice were determined
expression of IRF-1 and b-actin mRNA was detected as describedby immunoblotting.
in Experimental Procedures.
(B) Protein expression of IRF-1, IRF-2, and Cbl-2 in CD41CD81TCRlo,
CD41CD82TCRhi, and CD42CD81TCRhi thymocytes. Thymocytes
integrity and allows quantitation of cells undergoing apoptosis by (2 3 106/lane) were isolated from C57Bl/6 mice using a cell sorter and
cytometry (FL-3 channel on a FACScan). 7-AAD fluorescence can Western-blotted as described in Experimental Procedures. Post-
also be used to triple-stain apoptotic cells with other FITC (channel sorting purity of CD41CD81TCRlo, CD41CD82TCRhi, and CD42
FL1)± or PE (channel FL2)±labeled surface markers (Schmid et al., CD81TCRhi populations was .98%.
1994). Percentage survival was calculated as (total number of viable (C) Peptide-specific activation of P14 TCR Tg thymocytes induces
CD41CD81 thymocytes cultured at different LCMV peptide concen- up-regulation of IRF-1 protein. Thymocytes (5 3 106/lane) were iso-
trations)/(total number of viable CD41CD81 thymocytes from the lated from P14 b2m2/2 (Sebzda et al., 1994) and P14 CD452/2 (Kozie-
same mousecultured with MC57/L fibroblastsat 378C in theabsence radzki et al., 1997) mice and activated with adherent MC57/L fibro-
of peptide) 3 100. blast in the absence (control) or presence of 1029 mol/ml LCMV
peptide (Peptide). After 12 hr, nonadherent cell were harvested and
Bone Marrow Chimeras cell lysates Western-blotted for IRF-1, IRF-2, and Cbl-2 expression.
To construct bone marrow chimeras (Bevan, 1977; Zinkernagel et
al., 1978), bone marrow cells were isolated from 8-week-old Thy1.11
IRF-11/1 (H2b/b) or Thy1.21 IRF-12/2 (H2b/b) mice, and 2 3 107 T
control CBA (H-2k/k, nonselecting control stroma) mice were pre-cell±depleted bone marrow cells were intravenously transferred to
pared by enzymatic digestion of lymphocyte depleted thymi usingirradiated (925 rad) Thy1.21 IRF-12/2 or Thy1.11 B6PL-Thy.1Acy
0.15% collagenase/0.1% DNase (Boehringer Mannheim). Stromalmice, respectively. Chimeric mice were sacrificed after 4 months,
cells were enriched by elutriation (Lahoud et al., 1993), resuspendedand single-cell suspensions of thymocytes, spleen, and mesenteric
at a concentration of 6.7 3 105 cells/ml, and pulsed with 1029 mol/lymph node lymphocytes were double-stained with FITC-conju-
ml LCMV (amino acids 33±41) peptide. Thymocytes were mixed withgated CD8 and PE-labeled CD4. To determine chimerism, hemato-
the stromal cells at a ratio of 5:1 and cocultured as hanging dropspoietic cells were double-stained with FITC-labeled Thy1.1 and PE-
in inverted Terasaki plates at 378C (5% CO2). Cells were harvestedlabeled CD3, or Thy1.2-FITC and CD3-PE.
on day 4 and stained with anti-CD8 (biotin, visualized by RED670),
anti-CD4 (PE), Ly5.2 (FITC), and anti-CD3e (APC). Cells were ana-In Vitro Reaggregation Cultures
lyzed by flow cytometry. Tg Ly5.21 thymocytes were distinguishedStromal cell cultures for in vitro T cell selection have been described
from Ly5.11 congeneic stromal cells by Ly5.2 surface expression.(Chidgey et al., 1997). In brief, dual TCRVa21TCRVa111 thymocytes
were isolated from embryonic thymi (ED17) of P14 TCR Tg/b2m2/2
mice (Ly5.21). Sorted thymocytes (purity .98%) were prepared at Cell Sorting
Thymocytes were isolated from C57Bl/6 mice and triple stained fora concentration of 3.4 3 106 cells/ml in RPMI medium supplemented
with 2 mM L-glutamine (Flow, UK), 0.05% benzyl penicillia (CSL), CD4, CD8, and TCRab expression using anti-CD8-FITC, anti-CD4-
PE, and anti-TCRab-biotin. CD41CD81TCRlo, CD41CD82 TCRhi, and0.05% streptomycin (Sigma), 10% heat-inactivated FCS (Life Sci-
ences), and 5 3 1025 mol/ml 2-mercaptoethanol (Sigma). Stromal CD42CD81TCRhi populations were sorted using a FACS-Power
Sorter (Coulter). In all experiments, postsorting purity of CD41cells from Ly5.11 congeneic IRF-11/2 (H-2b/b), IRF-12/2 (H-2b/b), and
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